Work

Novel insights into the role of skeletal muscle autophagy in health and disease.

Year: 2016
Type: dissertation
Abstract: Structurally or functionally altered and unnecessary cellular components are physiologically removed from the cell through a self-degradative process named autophagy. An impairment of the autophagic machinery was shown to have a central role in the pathogenesis of several neurodegenerative, cardiac and age-related diseases. In the laboratory of Prof. Paolo Bonaldo, it was previously shown that an impairment of the autophagy pathway plays a key role in the pathogenesis of Bethlem Myopathy (BM) and Ullrich Congenital Muscular Dystrophy (UD), inherited human pathologies associated to collagen VI (COL6) deficiency and primarily affecting skeletal muscle. Moreover, autophagy reactivation by genetic, pharmacological and nutritional approaches was shown to rescue the dystrophic phenotype of Col6a1−/− mice, a model for human COL6-related myopathies. Although a large number of stimuli and molecules induce autophagy, their efficiency in counteracting muscle disease progression need to be carefully evaluated at the preclinical and clinical level. During my PhD I took part to the evaluation of the outcomes of a normocaloric low protein diet (LPD)-based clinical trial for BM and UD patients, whose results are very promising. Due to the low level of daily protein intake, LPD is however not safe for pediatric BM and UD patients and alternative autophagy-inducing strategies need to be identified. Toward this aim, I devoted a large part of my PhD work to investigate the effects of spermidine, a naturally occurring non-toxic autophagy-inducing molecule, on Col6a1−/− mice. I demostrated that spermidine administration reactivates autophagy in this pathological context, and this is paralleled by structural and functional ameliorations in COL6-deficient myopathic muscles. This work paves the way for the formulation of novel diet-based therapies for the treatment of BM and UD. Another major aim of my PhD project was investigating the mechanisms underlying autophagy regulation in skeletal muscle, focusing on AMBRA1 (activating molecule in BECN1-regulated autophagy). Studies in mice with a randomly mutated Ambra1 locus (Ambra1gt/gt) showed that this gene is essential for the development of the central nervous system, and may also play a key role for muscle development in zebrafish and mouse. To better clarify the role of AMBRA1 in skeletal muscles, we generated mice with a floxed Ambra1 allele (Ambra1f/f). I verified in vivo that the conditional allele for Ambra1 works properly, by breeding Ambra1f/f mice with a CAG-Cre transgenic line, which express Cre recombinase in the oocytes, to obtain the null allele for Ambra1. Mice bearing this allele either in homozygosity (Ambra1−/−) or in heterozygosity (Ambra1+/−) were preliminarily characterized. Moreover, I produced skeletal muscle-specific AMBRA1 null (Ambra1f/f::Mlc1f-Cre) mice and investigated muscle defects caused by AMBRA1 deficiency. Interestingly, data in adult Ambra1f/f::Mlc1f-Cre mice indicate that a high proportion of mature AMBRA1-deficient myofibers contain inclusion bodies. Ongoing experiments are aimed at identifying the composition of these inclusions and evaluating the activation status of autophagy and ubiquitin-proteasome system. The data I obtained until now exclude the presence of amyloid material in the inclusions, and highlight an impairment of both these degradation processes. As side projects, during my PhD I also participated in the study of autophagy status in other hereditary muscle pathologies. First, I contributed to the identification of an autophagy impairment in the tibialis anterior of mdx mice, a model for Duchenne Muscular Dystrophy. Then I was involved in the characterization of an aggresome-autophagy process occurring in muscle biopsies from a patient carrying a p.C150R mutation in the FHL1 gene, and affected by severe sarcopenia and rigid spine syndrome (RSS). It emerges from these studies that autophagy is a commonly dysregulated process in different muscle pathologies, and that autophagy modulation may be a promising therapeutic strategy in different pathological contexts. In summary, the data obtained with this PhD work underline the important pathogenetic role of autophagy dysregulation in congenital muscle pathologies, provide some basis for the development of novel therapeutic strategies based on autophagy modulation, and pave the way for unraveling the role of AMBRA1 in skeletal muscle.
Language: English
Open Access status: green
OpenAlex ID: W2560157011
Cites:
Cited by:
Related to: 10